Telposide is a medication used to improve glycemic control in patients with type 2 diabetes, particularly those with high postprandial blood glucose levels.

1. Telposide is a glucagon-like peptide-1 (GLP-1) receptor agonist. These drugs lower blood glucose levels by promoting insulin secretion, inhibiting glucagon release, and delaying gastric emptying. These mechanisms are particularly effective in controlling postprandial blood glucose.

2. Clinical trial data show that patients treated with telposide experienced a significant, on average, decrease in blood glucose levels within 2 hours after a meal, while the change in blood glucose levels was relatively smaller in the control group who did not use the medication.

3. In a 52-week study, telposide helped patients reduce their HbA1c (glycated hemoglobin) levels by an average of approximately 1.7%, signifying improved overall glycemic control, with a significant decrease in postprandial blood glucose.

4. Due to its mechanism of action, telposide helps reduce the risk of complications that may result from postprandial blood glucose fluctuations, including cardiovascular disease and nerve damage.